Stockscreener 앱 받기
25.89
4.40%
1.09
시간 외 거래:
25.89
전일 마감가:
$24.80
열려 있는:
$24.8
하루 거래량:
1.88M
Relative Volume:
1.66
시가총액:
$1.28B
수익:
$224.45M
순이익/손실:
$-95.27M
주가수익비율:
-13.41
EPS:
-1.93
순현금흐름:
$-43.74M
1주 성능:
+7.92%
1개월 성능:
-2.30%
6개월 성능:
+55.68%
1년 성능:
+1.77%
1일 변동 폭
$24.57
$26.18
1주일 범위
$23.03
$26.18
52주 변동 폭
$13.50
$30.81
Staar Surgical Co Stock (STAA) Company Profile
명칭
Staar Surgical Co
전화
(626) 303-7902
주소
1911 WALKER AVE, MONROVIA, CA
STAA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
25.89 | 1.22B | 224.45M | -95.27M | -43.74M | -1.93 |
|
ISRG
Intuitive Surgical Inc
|
556.86 | 196.60B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
195.36 | 56.05B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.26 | 38.81B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
245.94 | 36.10B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
269.13 | 19.17B | 2.96B | 487.70M | 344.00M | 6.6758 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-21 | 개시 | Wells Fargo | Equal Weight |
| 2025-02-12 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-02-12 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-02-12 | 다운그레이드 | Mizuho | Outperform → Neutral |
| 2025-02-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-07-15 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-06-11 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-03-11 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-05 | 다운그레이드 | Needham | Buy → Hold |
| 2023-12-04 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-09-15 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2023-08-03 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2023-06-07 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-04-17 | 개시 | Piper Sandler | Neutral |
| 2023-02-06 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-12-28 | 재확인 | BTIG Research | Buy |
| 2022-12-08 | 개시 | Stifel | Hold |
| 2022-11-07 | 업그레이드 | Sidoti | Neutral → Buy |
| 2022-10-14 | 재개 | Stephens | Overweight |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-04-08 | 개시 | Needham | Buy |
| 2022-03-28 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2022-03-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2021-07-09 | 개시 | Oppenheimer | Perform |
| 2021-01-19 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2020-10-26 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2020-08-31 | 업그레이드 | Sidoti | Neutral → Buy |
| 2020-08-06 | 재확인 | The Benchmark Company | Buy |
| 2020-07-06 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2020-06-24 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-06-15 | 개시 | Jefferies | Buy |
| 2019-12-04 | 개시 | BTIG Research | Buy |
| 2018-09-24 | 재확인 | The Benchmark Company | Buy |
| 2018-08-06 | 재개 | The Benchmark Company | Buy |
| 2017-11-20 | 재확인 | The Benchmark Company | Buy |
| 2017-08-14 | 재확인 | The Benchmark Company | Buy |
| 2017-03-03 | 재확인 | The Benchmark Company | Buy |
| 2016-05-18 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2013-09-10 | 재개 | The Benchmark Company | Buy |
| 2013-02-28 | 재확인 | The Benchmark Company | Buy |
| 2012-11-01 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2012-03-02 | 개시 | Northland Securities | Outperform |
| 2011-10-25 | 재확인 | The Benchmark Company | Buy |
| 2010-10-12 | 개시 | Morgan Joseph | Buy |
| 2010-05-11 | 개시 | Benchmark | Buy |
모두보기
Staar Surgical Co 주식(STAA)의 최신 뉴스
Broadwood sees $50/share path for STAAR Surgical as merger battle nears voting day - Investing.com India
Defender Capital to vote against STAAR Surgical sale to Alcon By Investing.com - Investing.com Nigeria
Defender Capital to vote against STAAR Surgical sale to Alcon - Investing.com India
Broadwood urges shareholders to reject Alcon’s bid for STAAR - Investing.com
Big STAAR investor fights Alcon buyout, says shares should hit $50 - Stock Titan
STAAR urges stockholders to vote for Alcon merger amid proxy battle - Investing.com Canada
STAAR Stockholders Have a Choice: Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value | ALC Stock News - Stock Titan
Yunqi Capital Comments on Proxy Advisors' Updated Recommendations, Urges Shareholders to Continue to Back the Company's Standalone Trajectory - marketscreener.com
ISS recommends STAAR Surgical deal, but warns shareholders have reason to object - Investing.com
Yunqi Capital to vote against revised Alcon-STAAR merger offer By Investing.com - Investing.com South Africa
Yunqi Capital to vote against revised Alcon-STAAR merger offer - Investing.com
Yunqi Capital says remains opposed to STAAR’s proposed merger with Alcon - TipRanks
Midday Stock Roundup: Shares of Aeon Biopharma, Staar Surgical Up - Orange County Business Journal
5.1% STAAR owner fights Alcon deal, arguing company is worth more - Stock Titan
STAAR Surgical (NASDAQ:STAA) Shares Gap UpTime to Buy? - MarketBeat
Alcon raises STAAR Surgical acquisition offer to $30.75 per share By Investing.com - Investing.com Nigeria
Alcon (NYSE: ALC) $30.75-per-share STAAR bid gains support from analysts and ISS - Stock Titan
Proxy firms raise concerns over STAAR Surgical’s proposed sale to Alcon - Investing.com Canada
Proxy firms raise concerns over STAAR Surgical’s proposed sale to Alcon By Investing.com - Investing.com South Africa
Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon - Markets Financial Content
Using the ICL as a supplementary IOL - EyeWorld
STAAR Surgical (STAA) Gains as ISS Backs Alcon's Improved Offer - GuruFocus
Battle for STAAR Surgical intensifies as Glass Lewis reiterates stance ’against’ - Investing.com Australia
Midday Stock Roundup: Rivian Rises on Chip, Models - Orange County Business Journal
STAAR Surgical (STAA) Faces Investor Pushback on Alcon Offer - GuruFocus
Glass Lewis Reaffirms its Recommendations to Shareholders of STAAR - marketscreener.com
Glass Lewis reaffirms opposition to Alcon’s STAAR acquisition bid - Investing.com
Glass Lewis reaffirms opposition to Alcon’s STAAR acquisition bid By Investing.com - Investing.com Australia
STAAR Surgical stock jumps 10% after Alcon sweetens buyout offer — investor says deal is 'worth substantially more' - MSN
STAAR Surgical accuses activist Broadwood of ’misinformation campaign’ - Investing.com
STAAR Surgical Rebuts Investor Claims Over Alcon Deal Process - Finimize
Why STAAR Surgical (STAA) Stock Is Up Today - Finviz
STAAR addresses activist investor claims about go-shop process By Investing.com - Investing.com Australia
STAAR Surgical (STAA): Assessing Valuation After Recent Share Price Weakness - Yahoo Finance UK
Broadwood continues opposition to STAAR’s acquisition by Alcon - Investing.com
Canaccord Genuity Raises Price Target for STAA, Reaffirms Hold R - GuruFocus
STAAR Surgical falls as Yunqi Capital reiterates opposition to merger with Alcon - Investing.com India
STAAR Surgical's Top Investors Reject Sweetened Alcon Offer, Cite Flawed Sale Process - Benzinga
STAAR Surgical (NASDAQ:STAA) Shares Gap DownWhat's Next? - MarketBeat
Alcon sweetens offer for Staar, major shareholders still unimpressed - BioWorld MedTech
Yunqi Capital Comments on STAAR Surgical?s Go-Shop Process - marketscreener.com
STAAR Surgical holder Yunqi Capital still against sale to Alcon (STAA:NASDAQ) - Seeking Alpha
STAAR Surgical Engages with its Employees - marketscreener.com
STAAR Surgical Acquisition by Alcon Opposed by Investor Yunqi Capital - marketscreener.com
Yunqi Capital opposes Alcon’s revised offer for STAAR Surgical - Investing.com
Yunqi Capital opposes Alcon’s revised offer for STAAR Surgical By Investing.com - Investing.com Australia
Yunqi Capital comments on Staar Surgical's go-shop process and Alcon's revised offer - marketscreener.com
Yunqi Capital Comments on STAAR Surgical’s Go-Shop Process and Alcon’s Revised Offer - marketscreener.com
Switzerland: Alcon agrees best and final offer with STAAR Surgical - Investors in Healthcare
Alcon lifts bid for medical technology firm Staar to $1.6 billion - WHTC
Mergers and acquisitions - TradingView
Staar Surgical Co (STAA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.26%
1.42%
자본화:
|
볼륨(24시간):